Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A clinical screening tool for objective and subjective cognitive disorders in multiple sclerosis.
Guilloton L, Camdessanche JP, Latombe D, Neuschwander P, Cantalloube S, Thomas-Anterion C, Mercier B, Roggerone S, Maucort-Boulch D, Roche S, Jacquin-Courtois S; “Cognition-MS” group of the Rhône-Alpes MS network. Guilloton L, et al. Among authors: neuschwander p. Ann Phys Rehabil Med. 2020 Mar;63(2):116-122. doi: 10.1016/j.rehab.2018.11.005. Epub 2019 Jan 29. Ann Phys Rehabil Med. 2020. PMID: 30703524 Free article.
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.
Papeix C, Castelnovo G, Leray E, Coustans M, Levy P, Visy JM, Kobelt G, Lamy F, Allaf B, Heintzmann F, Chouette I, Raponi E, Durand B, Grevat E, Kamar D, Debouverie M, Lebrun-Frenay C; Virgile Study Group. Papeix C, et al. Neurol Ther. 2022 Jun;11(2):633-658. doi: 10.1007/s40120-022-00334-y. Epub 2022 Feb 11. Neurol Ther. 2022. PMID: 35147904 Free PMC article.
[Cerebellar imitation synkineses].
Trouillas P, Brudon F, Froment JC, Nighoghossian N, Neuschwander P, Tommasi-Davenas C. Trouillas P, et al. Among authors: neuschwander p. Rev Neurol (Paris). 1990;146(2):107-15. Rev Neurol (Paris). 1990. PMID: 2181586 Review. French.
Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
Trouillas P, Nighoghossian N, Getenet JC, Riche G, Neuschwander P, Froment JC, Turjman F, Jin JX, Malicier D, Fournier G, Gabry AL, Ledoux X, Derex L, Berthezène Y, Adeleine P, Xie J, Ffrench P, Dechavanne M. Trouillas P, et al. Among authors: neuschwander p. Stroke. 1996 May;27(5):882-90. doi: 10.1161/01.str.27.5.882. Stroke. 1996. PMID: 8623108 Clinical Trial.
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
Trouillas P, Nighoghossian N, Derex L, Adeleine P, Honnorat J, Neuschwander P, Riche G, Getenet JC, Li W, Froment JC, Turjman F, Malicier D, Fournier G, Gabry AL, Ledoux X, Berthezène Y, Ffrench P, Dechavanne M. Trouillas P, et al. Among authors: neuschwander p. Stroke. 1998 Dec;29(12):2529-40. doi: 10.1161/01.str.29.12.2529. Stroke. 1998. PMID: 9836764 Clinical Trial.
rtPA intravenous thrombolysis in anterior choroidal artery territory stroke.
Trouillas P, Derex L, Nighoghossian N, Honnorat J, Li W, Neuschwander P, Riche G, Getenet JC, Berthezene Y, Turjman F, Froment JC, territory stroke. Trouillas P, et al. Among authors: neuschwander p. Neurology. 2000 Feb 8;54(3):666-73. doi: 10.1212/wnl.54.3.666. Neurology. 2000. PMID: 10680801
31 results